New hope for pancreatic cancer recurrence: targeted radiation trial underway
NCT ID NCT04881487
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding targeted radiation therapy (SBRT) to standard care helps people with pancreatic cancer that has returned only in the original area live longer and feel better. About 174 adults whose cancer came back locally after surgery will be randomly assigned to get SBRT plus usual care or usual care alone. The main goal is to see if the extra treatment extends survival after recurrence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Amsterdam University Medical Center, VUmc
RECRUITINGAmsterdam, North Holland, 1081 HV, Netherlands
-
Erasmus University Medical Center
RECRUITINGRotterdam, South Holland, 3015 GD, Netherlands
-
University Medical Center Utrecht
RECRUITINGUtrecht, Utrecht, 3584 CX, Netherlands